LTS Lohmann Therapie-Systeme AG

LTS Lohmann Therapie-Systeme AG is a pharmaceutical technology company founded in 1984, with the slogan "We CARE. We CREATE. We DELIVER." The company specializes in developing and manufacturing innovative drug delivery systems, including Transdermal Patches (TTS), Oral Thin Films (OTF), and wearable drug delivery devices (OBDS). LTS has a commercial offering of over 20 marketed products, and their pipeline includes over 40 development projects aimed at multiple disease indications. The company's innovation pipeline consists of both partner-funded and proprietary LTS-funded projects.

LTS maintains its leading position by continually refining its core TTS and OTF technologies, as well as advancing emerging drug delivery technologies such as Micro Array Patches (MAP) for the transdermal delivery of large molecule biological actives. Their SorrelTM wearable drug delivery platform offers patient-friendly solutions for complex drug delivery at home. The company operates from four sites: in Andernach, Germany; West Caldwell, NJ, USA; St. Paul, MN, USA; and Netanya, Israel. Additionally, LTS has a representative office in Shanghai, China.

Despite the lack of specific information about their last investment and investors, LTS Lohmann Therapie-Systeme AG's commitment to advancing drug delivery technologies and their substantial product portfolio position them as a significant player in the pharmaceutical industry. Their strong focus on innovation and diverse pipeline make them an attractive potential investment opportunity for venture capital firms.